As seen on:
As seen on:
Latest Articles
Raffles Medical Group’s 20% dividend increase highlights how strong cash flow and balance sheet strength can drive payouts beyond revenue growth.
Passive income sounds simple, but sustainable dividends require strong businesses underneath. These four Singapore stocks stand out for generating income while you stay invested for the long term.
This week’s Smart Reads highlights quarterly dividend stocks, the safest income payers on the SGX, and cash-rich names beating the STI. We also explore 52-week lows, REIT laggards, and how to build an inflation-proof portfolio.
We look at a landmark AI-powered IT deal involving a Singapore agri-business giant, a keenly contested Kallang waterfront land tender, and record-breaking property investment data for the first quarter of 2026.
Retail investors poured over S$300 million into S-REITs in March — but four of the top five saw DPU decline. Are these bargains or yield traps?
Three lesser-known SGX-listed companies saw insider buying in Q1 2026 – but can their dividends keep flowing?
Popular
As market sentiment improves and money flows back into equities, some stocks are better positioned than others to benefit from an upswing.
Starting your investing journey doesn’t mean chasing hot tips. These five types of stocks help new Singapore investors learn the basics while keeping risk manageable.
Build a resilient S$10,000 dividend engine for consistent passive income.
Earnings updates and strategic developments put these three Singapore stocks in focus for the week of 9 February 2026.
Stocks
Your 20s are the best time to start investing, but avoiding a few common mistakes can make a huge difference to your long-term wealth.
Three under-the-radar SGX stocks are buying back shares while paying dividends – but the sustainability of each payout tells a different story.
Sea Limited has evolved from a high-growth story into a more profitable business — but has it earned the right to be seen as a Blue Chip in 2026?
Three STI heavyweights led Singapore’s 4M2026 buyback tally with a combined S$636 million. For dividend investors, the more important question is what’s funding those returns – and whether the same engine can keep the dividends flowing.
Getting Started
Will technology stocks remain relevant in the brave new world?
The world faces a different kind of problem aside from the pandemic, but one that can be tackled with pharmaceuticals.
With a potential rocky and unsteady recovery post-COVID-19, here’s how you can locate stocks that will do well.
As enticing and appealing as cash might be, the problem is that there is a cost associated with keeping it.